Management of third molar removal with doses of native plasma-derived factor IX (Octanine) and local measures in a female patient with severe hemophilia B: a case report.
Quintessence Int. 2014 Mar;45(3):239-43. doi: 10.3290/j.qi.a31204.
Quintessence Int. 2014.
PMID: 24570991